Skip to main content
Premium Trial:

Request an Annual Quote

IonGate BioSciences Raises $6.8M in Third Funding Round

NEW YORK (GenomeWeb News) – IonGate BioSciences today announced that it has raised €4.6 million ($6.8 million) in a third round of private financing.
 
The Frankfurt, Germany-based firm said it would use the funds to expand its international business activities, to commercialize worldwide its SURFE2R technology, and to further develop its SURFE2R workstation. The SURFE2R technology analyzes electromagnetic membrane proteins, while the workstation is being developed to provide researchers with a direct functional characterization of transport proteins.
 
Last month, IonGate formed a subsidiary in New York that will assist in international marketing of the firm’s technology. Part of the proceeds from this round of financing will be used to establish distribution channels in the US, the firm said.
 
Investors in this round included Heidelberg Innovation and Kreditanstalt für Wiederaufbau.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.